Citation: Neurological Research and Practice 2019 1:7
Page 2 of 2
With the advent of modern immunotherapies for relapsing-remitting multiple sclerosis (RRMS) and the increasing amount of treatment options on the market, MS has evolved as a treatable disease. Yet, at the same...
Citation: Neurological Research and Practice 2019 1:5
Distribution and evolution of acute interventional ischemic stroke treatment in Germany from 2010 to 2016
Mechanical thrombectomy (MT) is a new evidence-based treatment option for large vessel occlusion in the anterior brain circulation. Using comprehensive administrative data from Germany, we analysed the nationw...
Citation: Neurological Research and Practice 2019 1:4
Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD)
Selective peripheral denervation via botulinum neurotoxin injections into dystonic muscles is the first-line treatment for cervical dystonia. Pallidal neurostimulation is a potent alternative, but currently re...
Citation: Neurological Research and Practice 2019 1:2
Interventional patent foramen ovale (PFO) closure should be performed in patients aged 16 to 60 years (after extensive neurological and cardiological diagnostic work-up) with a history of cryptogenic ischaemic...
Citation: Neurological Research and Practice 2019 1:1